On the Floor of the NYSE: Talking AI and the Future of Cancer Treatment
Ana Berry reports from the New York Stock Exchange, interviewing Lantern Pharma’s CEO about how AI is accelerating cancer drug development, LP-184 trial success, and the launch of Starlight Therapeutics. Learn how AI is transforming oncology.